Fulgent Genetics, Inc. (FLGT) vs Myriad Genetics, Inc. (MYGN)
Fulgent Genetics, Inc. and Myriad Genetics, Inc. are both Diagnostics & Research companies. Fulgent Genetics, Inc. is the larger, with a market value of $593.0M against $396.0M — 1.5× the size. Fulgent Genetics, Inc. grew revenue faster over the last twelve months: 6.83% against −3.16%. Myriad Genetics, Inc. has the higher net margin (−14.0% vs −26.1%) and the lower return on invested capital (−19.9% vs −10.3%). Across the 18 metrics below, Fulgent Genetics, Inc. leads on 9 and Myriad Genetics, Inc. on 9.
Valuation
Profitability
| Metric | FLGT | MYGN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 35.58% | 68.83% | 50.89% |
| Operating margin | (37.75%) | (12.22%) | (8.57%) |
| Net margin | (26.05%) | (13.96%) | (6.37%) |
| Free cash flow margin | (32.04%) | (1.76%) | 0.00% |
| Return on equity | (8.01%) | (32.54%) | (2.92%) |
| Return on assets | (7.37%) | (17.11%) | (6.71%) |
| Return on invested capital | (10.34%) | (19.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack